Treatment of delirium with ramelteon: Initial experience in three patients

General Hospital Psychiatry

Volumn 33, Issue 4, 2011, Pages 407-409

  Kimura, Ryo ^a   Mori, Kohji ^a   Kumazaki, Hirokazu ^a   Yanagida, Makoto ^a   Taguchi, Satoki ^a   Matsunaga, Hidenori ^a  

^a OSAKA GENERAL MEDICAL CENTER   (Japan)

Author keywords

Delirium; Melatonin; Ramelteon

Indexed keywords

ANTIBIOTIC AGENT; QUETIAPINE; RAMELTEON;

ADULT; AGED; ARTICLE; ASPIRATION PNEUMONIA; BALANCE IMPAIRMENT; CASE REPORT; CERVICAL SPINAL CORD INJURY; COMPUTER ASSISTED TOMOGRAPHY; DELIRIUM; DELUSION; DISEASE SEVERITY; DISORIENTATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG WITHDRAWAL; EXCITEMENT; FEMALE; FEVER; HUMAN; KIDNEY DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT TRANSPORT; PRESCRIPTION; PYELONEPHRITIS; RESTLESSNESS; SEPSIS; SLEEP DISORDER; SPUTUM; THORAX RADIOGRAPHY; VOMITING;

AGED; AGED, 80 AND OVER; DELIRIUM; FEMALE; HUMANS; INDENES; JAPAN; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SATISFACTION; SEVERITY OF ILLNESS INDEX;

EID: 79960213230     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2011.03.013     Document Type: Article

References (18)

1. Fong T.G., Tulebaev S.R., Inouye S.K. Delirium in elderly adults: diagnosis, prevention and treatment. Nat Rev Neurol 2009, 5:210-220.
2. Inouye S.K. Delirium in older persons. N Engl J Med 2006, 354:1157-1165.
3. Fricchione G.L., Nejad S.H., Esses J.A., et al. Postoperative delirium. Am J Psychiatry 2008, 165:803-812.
4. Glassman A.H., Bigger J.T. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry 2001, 158:1774-1782.
5. Tabet N., Howard R. Pharmacological treatment for the prevention of delirium: review of current evidence. Int J Geriatr Psychiatry 2009, 24:1037-1044.
6. Al-Aama T., Brymer C., Gutmanis I., et al. Melatonin decreases delirium in elderly patients: a randomized, placebo-controlled trial. Int J Geriatr Psychiatry 2010.
7. Hanania M., Kitain E. Melatonin for treatment and prevention of postoperative delirium. Anesth Analg 2002, 94:338-339.
8. Kato K., Hirai K., Nishiyama K., et al. Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist. Neuropharmacology 2005, 48:301-310.
9. American Psychiatric Association Diagnostic criteria from DSM-IV-TR 2000, American Psychiatric Association, Washington (DC), [xii, 370 p].
10. Matsuoka Y., Miyake Y., Arakaki H., et al. Clinical utility and validation of the Japanese version of Memorial Delirium Assessment Scale in a psychogeriatric inpatient setting. Gen Hosp Psychiatry 2001, 23:36-40.
11. Shinno H., Matsuoka T., Yamamoto O., et al. Successful treatment with quetiapine for delirium in terminally ill cancer patients. Psychogeriatrics 2007, 7:64-68.
12. Witlox J., Eurelings L.S., de Jonghe J.F., et al. Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis. JAMA 2010, 304:443-451.
13. Wang P.S., Schneeweiss S., Avorn J., et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 2005, 353:2335-2341.
14. Gunther M.L., Morandi A., Ely E.W. Pathophysiology of delirium in the intensive care unit. Crit Care Clin 2008, 24:45-65.
15. Lipowski Z.J. Delirium (acute confusional states). JAMA 1987, 258:1789-1792.
16. Bourne R.S., Mills G.H. Melatonin: possible implications for the postoperative and critically ill patient. Intensive Care Med 2006, 32:371-379.
17. Srinivasan V., Kaur C., Pandi-Perumal S., Brown G.M., Cardinali D.P. Melatonin and its agonist ramelteon in Alzheimer's disease: possible therapeutic value. Int J Alzheimer's Dis 2011.
18. Sateia M.J., Kirby-Long P., Taylor J.L. Efficacy and clinical safety of ramelteon: an evidence-based review. Sleep Med Rev 2008, 12:319-332.